Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Huorka

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Bratislavske Lekarske Listy|August 16, 2013
The prevalence and risk factors for osteoporosis in patients with inflammatory bowel diseaseE Miznerova, T Hlavaty, T Koller, et al.
Physiological Research|December 18, 2019
Pathophysiology and risk factors for cholelithiasis in patients with Crohn's diseaseI Sturdik, A Krajcovicova, Y Jalali, et al.
Bratislavske Lekarske Listy|May 24, 2012
Prevalence of mutations in thiopurine S-methyltransferase gene among Slovak IBD patientsB Desatova, T Hlavaty, D Balakova, et al.
Bratislavske Lekarske Listy|June 5, 2013
Prevalence of mutations in thiopurine S-methyltransferase gene among Slovak IBD patientsB Desatova, T Hlavaty, D Balakova, et al.
Acta Gastro-Enterologica Belgica|January 16, 2019
Dosing interval and diagnosis predict infliximab levels in patients with inflammatory bowel disease on maintenance treatmentA Krajcovicova, M Batovsky, M Gregus, et al.
Bratislavske Lekarske Listy|August 31, 2018
Influence of vitamin D on the expression of mRNA of cytokines in the mucosa of inflammatory bowel disease patientsZ Vrablicova, K Soltys, A Krajcovicova, et al.
Physiological Research|December 18, 2019
Impact of smoking cigarette on the mRNA expression of cytokines in mucosa of inflammatory bowel diseaseZ Vrablicova, K Soltys, A Krajcovicova, et al.
Bratislavske Lekarske Listy|March 22, 2013
The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseasesT Hlavaty, M Batovsky, D Balakova, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Bratislavske Lekarske Listy|August 16, 2013
The prevalence and risk factors for osteoporosis in patients with inflammatory bowel diseaseE Miznerova, T Hlavaty, T Koller, et al.
Physiological Research|December 18, 2019
Pathophysiology and risk factors for cholelithiasis in patients with Crohn's diseaseI Sturdik, A Krajcovicova, Y Jalali, et al.
Bratislavske Lekarske Listy|May 24, 2012
Prevalence of mutations in thiopurine S-methyltransferase gene among Slovak IBD patientsB Desatova, T Hlavaty, D Balakova, et al.
Bratislavske Lekarske Listy|June 5, 2013
Prevalence of mutations in thiopurine S-methyltransferase gene among Slovak IBD patientsB Desatova, T Hlavaty, D Balakova, et al.
Acta Gastro-Enterologica Belgica|January 16, 2019
Dosing interval and diagnosis predict infliximab levels in patients with inflammatory bowel disease on maintenance treatmentA Krajcovicova, M Batovsky, M Gregus, et al.
Bratislavske Lekarske Listy|August 31, 2018
Influence of vitamin D on the expression of mRNA of cytokines in the mucosa of inflammatory bowel disease patientsZ Vrablicova, K Soltys, A Krajcovicova, et al.
Physiological Research|December 18, 2019
Impact of smoking cigarette on the mRNA expression of cytokines in mucosa of inflammatory bowel diseaseZ Vrablicova, K Soltys, A Krajcovicova, et al.
Bratislavske Lekarske Listy|March 22, 2013
The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseasesT Hlavaty, M Batovsky, D Balakova, et al.
Pageof 4